v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 68,490 $ 78,459
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 55,221 56,343
Costs recognized on sale of acquired inventory 373 364
Deferred income taxes (13,417) (22,314)
Stock-based compensation expense 24,892 22,846
Fair value adjustment to contingent consideration payable 0 (3,500)
Fair value adjustment on available-for-sale investments 0 (283)
(Gain) Loss on equity method investment (420) 4,295
Asset impairment restructuring 9,841 0
Leases, net 492 1,196
Impairment of assets held-for-sale 0 6,038
Other operating activity 305 256
Change in operating assets and operating liabilities, net of acquisition:    
Trade accounts and other receivables, net 20,940 20,333
Inventories (11,713) (9,577)
Prepaid expenses (405) (3,149)
Trade accounts payable, accrued expenses, contract liabilities, and other (29) 5,382
Salaries, wages and related accruals 3,882 (4,305)
Income taxes payable (10,217) (9,885)
Net cash provided by (used in) operating activities 148,235 142,499
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of available-for-sale investments 1,085 23,759
Purchases of available-for-sale investments 0 (5,526)
Additions to property and equipment (15,993) (28,456)
Acquisitions, net of cash acquired 0 (169,707)
Distributions from (Investments in) Wilson Wolf 1,403 2,149
Investment in Spear Bio (15,000) 0
Proceeds from sale of assets held-for-sale 1,789 0
Net cash provided by (used in) investing activities (26,716) (177,781)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (25,424) (25,213)
Proceeds from stock option exercises 30,641 19,670
Re-purchases of common stock (75,628) (80,042)
Borrowings under line-of-credit agreement 0 225,000
Repayments of long-term debt (19,000) (128,000)
Taxes paid on RSUs and net share settlements (5,997) (21,302)
Net cash provided by (used in) financing activities (95,408) (9,887)
Effect of exchange rate changes on cash and cash equivalents (353) (5,270)
Net change in cash and cash equivalents 25,758 (50,439)
Cash and cash equivalents at beginning of period 151,791 180,571
Cash and cash equivalents at end of period 177,549 130,132
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 37,593 37,645
Cash paid for interest $ 9,831 $ 8,586

Source